Treatment of Stage IV Non–Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam

INTRODUCTION: Lung cancer has been one of the most prevalent cancers worldwide in recent decades. According to the findings of the KEYNOTE-407 (2018) study on patients with stage IV squamous cell lung cancer, the combination of pembrolizumab and chemotherapy in the first-line treatment prolongs over...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Khanh Toan, Van, To Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448733/
https://www.ncbi.nlm.nih.gov/pubmed/37637233
http://dx.doi.org/10.36401/JIPO-23-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448733/
https://www.ncbi.nlm.nih.gov/pubmed/37637233
http://dx.doi.org/10.36401/JIPO-23-12

Ejemplares similares